Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome

Neurology

Volumn 57, Issue 8, 2001, Pages 1519-

  Kompoliti, Katie ^a,c   Goetz, C G ^a   Leurgans, S ^b   Raman, R ^b   Comella, C L ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Section of Movement Disorders   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONAZEPAM; ESTROGEN; FLUOXETINE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION FUNCTION; DISEASE SEVERITY; ESTROGEN BLOOD LEVEL; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MENSTRUAL CYCLE; OBSESSION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 0035940622     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.8.1519     Document Type: Article

References (6)

1. Effects of estrogen on the basal ganglia
2. A clinical study of Gilles de la Tourette syndrome in the United Kingdom
3. Menstrual cycle-related fluctuations of tics in Tourette syndrome
4. Estrogen as adjuvant treatment of Tourette syndrome
5. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome
6. Talipexole and adult Gilles de la Tourette's syndrome: Double-blind, placebo-controlled clinical trial